Drug – bio-affecting and body treating compositions – Preparations characterized by special physical form – Particulate form
Reexamination Certificate
2005-02-15
2005-02-15
Page, Thurman K. (Department: 1615)
Drug, bio-affecting and body treating compositions
Preparations characterized by special physical form
Particulate form
C424S489000, C424S493000, C424S497000
Reexamination Certificate
active
06855336
ABSTRACT:
A stable pharmaceutical composition of omeprazole for oral administration which consists essentially of: (a) a core of Omeprazole or a pharmaceutically equivalent salt, a filler and an alkaline material selected from the group consisting of lysing and arginine; and (b) a single layer of coating on said core which comprises a layer of an enteric coating agent which is applied from an organic solvent based system.
REFERENCES:
patent: 4045563 (1977-08-01), Berntsson et al.
patent: 4045564 (1977-08-01), Berntsson et al.
patent: 4182766 (1980-01-01), Krasso et al.
patent: 4255431 (1981-03-01), Junggren et al.
patent: 4337257 (1982-06-01), Junggren et al.
patent: 4359465 (1982-11-01), Ruwart
patent: 4432966 (1984-02-01), Zeitoun et al.
patent: 4508905 (1985-04-01), Junggren et al.
patent: 4544750 (1985-10-01), Brandstrom et al.
patent: 4620008 (1986-10-01), Brandstrom et al.
patent: 4636499 (1987-01-01), Brandstrom et al.
patent: 4686230 (1987-08-01), Rainer et al.
patent: 4738974 (1988-04-01), Brandstrom et al.
patent: 4786505 (1988-11-01), Lovgren et al.
patent: 4840799 (1989-06-01), Appeigren et al.
patent: 4853230 (1989-08-01), Lovgren et al.
patent: 5045321 (1991-09-01), Makino et al.
patent: 5093132 (1992-03-01), Makino et al.
patent: 5093342 (1992-03-01), Tomoi et al.
patent: 5178867 (1993-01-01), Guittard et al.
patent: 5204118 (1993-04-01), Goldman et al.
patent: 5244670 (1993-09-01), Upson et al.
patent: 5288506 (1994-02-01), Spickett et al.
patent: 5304540 (1994-04-01), Blackburn et al.
patent: 5330982 (1994-07-01), Tyers
patent: 5352688 (1994-10-01), Kaminski
patent: 5362424 (1994-11-01), Lee et al.
patent: 5385739 (1995-01-01), Debregeas et al.
patent: 5389664 (1995-02-01), Baile et al.
patent: 5399700 (1995-03-01), Min et al.
patent: 5417980 (1995-05-01), Goldman et al.
patent: 5433959 (1995-07-01), Makino et al.
patent: 5508041 (1996-04-01), Lee et al.
patent: 5518730 (1996-05-01), Fuisz
patent: 5599794 (1997-02-01), Eek et al.
patent: 5620964 (1997-04-01), Roth et al.
patent: 5622717 (1997-04-01), Fuisz
patent: 5637320 (1997-06-01), Bourke et al.
patent: 5639478 (1997-06-01), Makino et al.
patent: 5693818 (1997-12-01), Von Unge
patent: 5753265 (1998-05-01), Bergstrand et al.
patent: 6013281 (2000-01-01), Lundberg et al.
patent: 6096340 (2000-08-01), Chen et al.
patent: 20040166162 (2004-08-01), Niecestro et al.
patent: 1129417 (1982-08-01), None
patent: 1127158 (1985-07-01), None
patent: 1234118 (1988-03-01), None
patent: 1263119 (1989-11-01), None
patent: 1264751 (1990-01-01), None
patent: 1292693 (1991-12-01), None
patent: 2083605 (1991-12-01), None
patent: 1302891 (1992-06-01), None
patent: 2046364 (1993-01-01), None
patent: 1324758 (1993-11-01), None
patent: 2140347 (1994-02-01), None
patent: 2139653 (1994-12-01), None
patent: 2170647 (1996-01-01), None
patent: 2193681 (1996-01-01), None
patent: 1338377 (1996-06-01), None
patent: 2037101 (1997-03-01), None
patent: 2166794 (1997-03-01), None
patent: 2166483 (1997-09-01), None
patent: 124495 (1984-07-01), None
patent: 1010423 (2000-06-01), None
patent: 1234058 (1971-06-01), None
patent: 9208161 (1992-09-01), None
patent: WO 8503436 (1985-08-01), None
patent: WO 9501783 (1995-01-01), None
patent: WO 9510264 (1995-04-01), None
patent: WO 9512590 (1995-05-01), None
patent: WO 9601612 (1996-01-01), None
patent: WO 9601622 (1996-01-01), None
patent: WO 9601623 (1996-01-01), None
patent: WO 9602535 (1996-02-01), None
patent: WO 9624338 (1996-08-01), None
patent: WO 9624375 (1996-08-01), None
patent: WO 9840069 (1998-09-01), None
L. Olbe, S.E. et al., Present Situation and Future Prospects of Medical Treatment., Gastrins and the Vagus, Academic Press p. 245-250, 1979.
Ekenved et al. Studies with H 168/68, a Novel Gastric Acid Secretion Inhibition., Gut, vol. 22, p. A877, No. 10, Oct. 1981.
Erik Fellenius et al., Substituted Benzimidazoles Inhibit Gastric Acid Secretion by Blocking (H++K+) ATPase, Nature, vol. 290, p. 159-161, Mar. 12, 1981.
Tore Lind, et al. Effect of Omeprazole—A Gastric Proton Pump Inhibitor on Pentagastrin Stimulated Acid Secretion in Man., Gut, vol. 24 p. 270-276, 1983.
K-Fr Sewin et al., Effect of Substituted Benzimidazoles on Acid Secretion in Isolated and Enriched Guinea Pig Parietal Cells., Gut, vol. 24 p. 557-560, Jun. 1983.
Haken Larsson et al., Inhibition of Gastric Acid Secretion by Omeprazole in the Dog and the Rat. Gastroenterology, vol. 85 p. 900-907, Oct. 1983.
Walter Londong et al. Dose-Response Study of Omeprazole on Meal Stimulated Gastric Acid and Gastrin Release., Gastroenterology, vol. 85 p. 1373-1378, Dec. 1983.
Stanislaw J., Effects of Omeprazole, a Substituted Benzimidazole, on Gastrointestinal Secretions, Serum Gastrin and Gastric Mucosal Blood Flow in Dogs., Gastroenterology, vol. 86 p. 71-77 Jan. 1984.
D.A. Henry et al., Omeprazole: Effects on Oxidative Drug Metabolism., British Journal of Clinical Pharmacology, vol. 18, p. 195-200, Aug. 1984.
B.K. Sharma et al. Optimal Dose of Oral Omeprazole for Maximal 24 Hour Decrease of Intragastric Acidity., Gut, vol. 25, p. 957-964, Sep. 1984.
H.P.M. Festen et al., Effect of Oral Omeprazole on Serum Gastrin and Serum Pepsinogen I Levels., Gastroenterology, vol. 87 p. 1030-1034, Nov. 1984.
Peter Prichard et al. Omeprazole: A Study of Its Inhibition of Gastric pH and Oral Pharmacokinetics After Morning or Evening Dosages., Gastroenterology, vol. 88, p. 64-69 Jan. 1985.
K.O. Borg and L. Olbe, Omeprazole—A Survey of Preclinical Data., Gastroenterology, p. 15-22, 37-51, 71-77, 79-93, 105-120, Jun. 1985.
50th Edition of Physician's Desk Reference p. 529-531, 1996.
K.O. Borg, and L. Olbe, Proceedings of the First International Symposium on Omeprazole Supplement to the Scandinavian Journal of Gastroenterology, pp. 11-17, 31-38, 54-56, 59-60, 75-78, 89-135, 179, 182-183, 187-195, 1996.
Sep. 23, 1994 Decision of the Korean Patent Office Regarding Korean Patent No. 55426 (with Certified English Translation).
Chen Chih-Ming
Chou Joseph
Kositprapa Unchalee
ANDRX Pharmaceuticals, Inc.
Hedman & Costigan ,P.C.
Page Thurman K.
Tran S.
LandOfFree
Omeprazole formulation does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Omeprazole formulation, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Omeprazole formulation will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3474141